Rayonier Advanced Materials ( (RYAM) ) has released its Q3 earnings. Here is a breakdown of the information Rayonier Advanced Materials presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Rayonier Advanced Materials Inc. is a global leader in cellulose-based technologies, specializing in cellulose specialties, biomaterials, and other industrial applications with operations in the U.S., Canada, and France. The company reported its third-quarter 2025 results, highlighting a net sales decrease to $353 million and a reduced loss from continuing operations of $4 million compared to the previous year. Despite a challenging environment, the company maintained its strategic focus on its core Cellulose Specialties business, which showed resilience and approached normalized levels.
Key financial metrics for the quarter included an adjusted EBITDA of $42 million, a decrease from the previous year, and a total debt of $794 million. The company faced a decline in net sales across most segments, with the Cellulose Specialties segment experiencing a 12% decrease in sales due to customer destocking and global tariff impacts. However, the segment’s operating income increased by 7% due to higher average sales prices and lower fixed costs. The company also reported improvements in the Cellulose Commodities segment, with a significant reduction in operating loss driven by increased sales prices and lower fixed costs.
The company continues to expect a strong finish to 2025, with annual adjusted EBITDA projected to reach $135 million to $140 million. Looking ahead, Rayonier Advanced Materials aims to more than double its EBITDA over the next two years through price actions, efficiency gains, and cost reductions. The company is also exploring strategic opportunities in its Biomaterials segment, aiming to enhance profitability and end-market diversity.
In conclusion, Rayonier Advanced Materials remains committed to its long-term strategy of achieving over $300 million in run-rate EBITDA by the end of 2027. The company plans to focus on cash management, liquidity, and disciplined capital allocation to support its growth objectives and deliver sustainable value to shareholders.